Dr. Erva Khan is a New York, New York based psychiatrist who is specialized in Child & Adolescent. Active license number of Dr. Erva Khan is 319466 for Psychiatry in New York. Her current practice location is 15 W 136th St, New York. Patients can reach her at 212-939-3370. Dr. Erva Khan NPI number (Unique professional ID assigned by NPPES) is 1790312106. Dr. Erva Khan has done additional skills and training in the diagnosis and treatment of developmental, behavioral, emotional, and mental disorders of childhood and adolescence.
Complete Profile:
Dr. Erva Khan speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Erva Khan
Specialization:
Child & Adolescent
Gender:
Female
Practice Address:
15 W 136th St, New York, New York, 10037-2104
Phone:
212-939-3370
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1790312106
NPI Enumeration Date:
25 Mar, 2020
NPI Last Update On:
28 Aug, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Erva Khan are as mentioned below.
License Number
Specialization
State
Status
319466
Psychiatry
New York
Primary
319466
Child & Adolescent
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Erva Khan 317 E 17th St, New York, New York
Zip:
10003-3804
Patients can reach Dr. Erva Khan at 15 W 136th St, New York, New York or can call to book an appointment on 212-939-3370.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.